The incidence of acute cardiovascular events, including myocardial infarction and ischemic stroke, is increased in individuals with COVID-19. A study shows that SARS-CoV-2 can directly infect macrophages and foam cells in atherosclerotic plaques and contribute to plaque instability.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Giacca, M. & Shah, A. M. Nat. Cardiovasc. Res. 1, 200–210 (2022).
Katsoularis, I., Fonseca-Rodriguez, O., Farrington, P., Lindmark, K. & Fors Connolly, A. M. Lancet 398, 599–607 (2021).
Shi, S. et al. Eur. Heart J. 41, 2070–2079 (2020).
Shi, S. et al. JAMA Cardiol. 5, 802–810 (2020).
Lala, A. et al. J. Am. Coll. Cardiol. 76, 533–546 (2020).
Eberhardt, N. et al. Nat. Cardiovas. Res. https://doi.org/10.1038/s44161-023-00336-5 (2023).
Bussani, R. et al. J. Pathol. 259, 254–263 (2023).
Ackermann, M. et al. N. Engl. J. Med. 383, 120–128 (2020).
Bussani, R. et al. EBioMedicine 61, 103104 (2020).
Braga, L. et al. Nature 594, 8–93 (2021).
Cappelletto, A. et al. Front Cardiovasc. Med. 9, 1013262 (2022).
Lemke, G. Nat. Rev. Immunol. 19, 539–549 (2019).
Xie, Y., Xu, E., Bowe, B. & Al-Aly, Z. Nat. Med. 28, 583–590 (2022).
Zakeri, R. et al. EClinicalMedicine 28, 100574 (2020).
Nafilyan, V. et al. Eur. J. Epidemiol. 36, 605–617 (2021).
Acknowledgements
Work in the Giacca laboratory is supported by the European Research Council (ERC) Advanced Grant 787971 ‘CuRE’; British Heart Foundation (BHF) program grant RG/19/11/34633; King’s College London BHF Centre of Research Excellence grant RE/18/2/34213; grants 825670 ‘CardioReGenix’ and 874764 ‘REANIMA’ from the European Commission Horizon 2020 program.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
M.G. is founder, consultant, member of the Board and equity holder in Forcefield Therapeutics, Heqet Therapeutics and Purespring Therapeutics.
Rights and permissions
About this article
Cite this article
Giacca, M. SARS-CoV-2 infection boosts inflammation in atherosclerotic plaques. Nat Cardiovasc Res 2, 966–967 (2023). https://doi.org/10.1038/s44161-023-00358-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-023-00358-z